Volker Ehemann
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 8
- RNA Interference and Gene Delivery 7
- Glycosylation and Glycoproteins Research 4
- Neurology 18
- Neuroblastoma Research and Treatments 16
- Co-authors
- Manfred Schwab (9 shared papers)Peter Schirmacher (17 shared papers)Sabine Zitzmann (2 shared papers)Frank Westermann (12 shared papers)Thomas Longerich (5 shared papers)Michael Cantz (2 shared papers)Jürgen Kopitz (2 shared papers)Kai Breuhahn (11 shared papers)
- Journals
- Cancer Letters (7 papers)Hepatology (6 papers)International Journal of Medical Sciences (4 papers)Radiation Oncology (3 papers)Cancer Research (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Volker Ehemann
96 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 670
- Oncology 768
- Molecular Biology 2.1k
- Neurology 402
- Cell Biology 414
Countries citing papers authored by Volker Ehemann
This map shows the geographic impact of Volker Ehemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Ehemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Ehemann more than expected).
Fields of papers citing papers by Volker Ehemann
This network shows the impact of papers produced by Volker Ehemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Ehemann. The network helps show where Volker Ehemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Volker Ehemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 251 | |
| 2 | Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. | 2002 | 243 |
| 3 | 2007 | 166 | |
| 4 | 2013 | 165 | |
| 5 | 2011 | 133 | |
| 6 | 2009 | 132 | |
| 7 | 2012 | 130 | |
| 8 | 2009 | 104 | |
| 9 | 2007 | 101 | |
| 10 | 2008 | 95 | |
| 11 | 1998 | 89 | |
| 12 | 2009 | 84 | |
| 13 | 2010 | 82 | |
| 14 | 1998 | 80 | |
| 15 | 2011 | 72 | |
| 16 | Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. | 1997 | 67 |
| 17 | 2011 | 66 | |
| 18 | 2010 | 60 | |
| 19 | 2003 | 54 | |
| 20 | 2007 | 52 |
About Volker Ehemann
Volker Ehemann is a scholar working on Molecular Biology, Neurology, Oncology, Cancer Research and Cell Biology, having authored 96 papers that have together received 3.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (16 papers), Microtubule and mitosis dynamics (9 papers), Cancer-related Molecular Pathways (8 papers), Histone Deacetylase Inhibitors Research (8 papers), RNA Interference and Gene Delivery (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Musculoskeletal synovial abnormalities and treatments (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (670 citations), Oncology (768 citations), Molecular Biology (2.1k citations), Neurology (402 citations) and Cell Biology (414 citations). Volker Ehemann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Manfred Schwab, Peter Schirmacher, Sabine Zitzmann, Frank Westermann, Thomas Longerich, Michael Cantz, Jürgen Kopitz, Kai Breuhahn, Matthias Fischer and Jürgen Debus. Their work appears in journals such as Cancer Letters, Hepatology, International Journal of Medical Sciences, Radiation Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.